Want to see SE:IMMNOV full AI Analyst Report?
Immunovia AB (IMMNOV) Ratios
4 Followers
Immunovia AB Ratios
SE:IMMNOV's free cash flow for Q3 2026 was kr-14.91M. For the 2026 fiscal year, SE:IMMNOV's free cash flow was increased by kr0.00 and operating cash flow was kr-14.91M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.12 | 1.34 | 2.69 | 4.80 | 9.07 |
| Quick Ratio | 5.12 | 1.34 | 2.69 | 4.72 | 9.01 |
| Cash Ratio | 4.94 | 1.18 | 2.57 | 4.40 | 8.78 |
| Solvency Ratio | -6.12 | -2.95 | -5.29 | -2.12 | -2.31 |
| Operating Cash Flow Ratio | -5.00 | -4.52 | -4.92 | -7.29 | -4.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 56.93M | kr 7.20M | kr 48.82M | kr 58.83M | kr 237.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.04 | 0.13 | 0.07 |
| Debt-to-Equity Ratio | 0.01 | 0.06 | 0.06 | 0.15 | 0.08 |
| Debt-to-Capital Ratio | 0.01 | 0.06 | 0.06 | 0.13 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.36 | 2.84 | 1.47 | 1.23 | 1.14 |
| Debt Service Coverage Ratio | -1.17 | -32.94 | -142.85 | -74.08 | -95.60 |
| Interest Coverage Ratio | -1.20 | -58.82 | -254.25 | -119.47 | -116.44 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.19 | 0.03 | 0.14 | 1.61 | 1.42 |
| Net Debt to EBITDA | 0.99 | 0.40 | 0.44 | 0.48 | 1.88 |
| Profitability Margins | |||||
| Gross Profit Margin | -11606.42% | 100.00% | -324.25% | -267.77% | 1873.58% |
| EBIT Margin | -11606.42% | -8021.59% | -19573.21% | -14540.79% | -18309.72% |
| EBITDA Margin | -11267.01% | -6580.56% | -10575.17% | -12364.98% | -16051.07% |
| Operating Profit Margin | -11606.42% | -11751.99% | -18822.86% | -16694.32% | -19756.04% |
| Pretax Profit Margin | -21301.46% | -8221.37% | -19646.92% | -14680.52% | -18479.38% |
| Net Profit Margin | -21301.46% | -8221.37% | -19646.92% | -12666.72% | -18649.05% |
| Continuous Operations Profit Margin | -21301.46% | -8221.37% | -19646.92% | -14680.52% | -18479.38% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 86.28% | 100.92% |
| EBT Per EBIT | 183.53% | 69.96% | 104.38% | 87.94% | 93.54% |
| Return on Assets (ROA) | -165.41% | -231.65% | -313.58% | -48.25% | -31.87% |
| Return on Equity (ROE) | -225.40% | -657.06% | -461.91% | -59.49% | -36.27% |
| Return on Capital Employed (ROCE) | -109.63% | -939.23% | -431.04% | -69.13% | -36.16% |
| Return on Invested Capital (ROIC) | -108.35% | -887.43% | -415.93% | -58.61% | -35.69% |
| Return on Tangible Assets | -179.04% | -246.10% | -321.88% | -86.85% | -45.33% |
| Earnings Yield | -186.68% | -218.24% | -449.06% | -24.36% | -9.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.52 | 0.34 | 1.09 | 0.31 | 0.19 |
| Payables Turnover | 14.21 | 123.30 | 0.79 | 2.67 | -4.88 |
| Inventory Turnover | 673.86 | 0.00 | 0.00 | 2.09 | -6.96 |
| Fixed Asset Turnover | 0.71 | 0.48 | 0.10 | 0.02 | 0.02 |
| Asset Turnover | 0.01 | 0.03 | 0.02 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 |
| Cash Conversion Cycle | 671.28 | 1079.10 | -127.54 | 1200.95 | 1961.53 |
| Days of Sales Outstanding | 696.43 | 1082.06 | 335.57 | 1162.90 | 1939.17 |
| Days of Inventory Outstanding | 0.54 | 0.00 | 0.00 | 174.74 | -52.43 |
| Days of Payables Outstanding | 25.69 | 2.96 | 463.11 | 136.69 | -74.78 |
| Operating Cycle | 696.97 | 1082.06 | 335.57 | 1337.64 | 1886.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.23 | -1.17 | -3.78 | -7.20 | -6.26 |
| Free Cash Flow Per Share | -0.23 | -1.17 | -3.80 | -7.27 | -7.25 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -138.60 | -108.12 | -6.31 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -138.60 | -108.12 | -6.31 |
| Operating Cash Flow Coverage Ratio | -91.48 | -142.28 | -34.31 | -4.67 | -4.59 |
| Operating Cash Flow to Sales Ratio | -114.45 | -103.92 | -93.37 | -153.35 | -180.86 |
| Free Cash Flow Yield | -100.30% | -275.86% | -214.95% | -29.77% | -10.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.54 | -0.46 | -0.22 | -4.10 | -10.78 |
| Price-to-Sales (P/S) Ratio | 114.10 | 37.67 | 43.75 | 519.88 | 2010.97 |
| Price-to-Book (P/B) Ratio | 1.21 | 3.01 | 1.03 | 2.44 | 3.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.00 | -0.36 | -0.47 | -3.36 | -9.60 |
| Price-to-Operating Cash Flow Ratio | -1.00 | -0.36 | -0.47 | -3.39 | -11.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.01 | -0.01 | 0.53 | -17.28 |
| Enterprise Value Multiple | -0.02 | -0.17 | 0.02 | -3.72 | -10.65 |
| Enterprise Value | 1.56M | 10.43M | -3.59M | 526.79M | 1.44B |
| EV to EBITDA | -0.02 | -0.17 | 0.02 | -3.72 | -10.65 |
| EV to Sales | 2.28 | 11.21 | -2.28 | 460.08 | 1709.85 |
| EV to Free Cash Flow | -0.02 | -0.11 | 0.02 | -2.97 | -8.16 |
| EV to Operating Cash Flow | -0.02 | -0.11 | 0.02 | -3.00 | -9.45 |
| Tangible Book Value Per Share | 0.17 | 0.12 | 1.66 | 4.52 | 11.78 |
| Shareholders’ Equity Per Share | 0.19 | 0.14 | 1.72 | 10.00 | 17.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.14 | -0.01 |
| Revenue Per Share | 0.00 | 0.01 | 0.04 | 0.05 | 0.03 |
| Net Income Per Share | -0.42 | -0.93 | -7.95 | -5.95 | -6.45 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.86 | 1.01 |
| Interest Burden | 1.84 | 1.02 | 1.00 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 30.56 | 21.85 | 41.84 | 50.95 |
| SG&A to Revenue | 0.00 | -30.56 | 0.00 | 0.00 | 97.88 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.54 | 0.88 | 0.48 | 0.92 | 0.92 |
Currency in SEK
